Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform.
about
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platformFungal diseases: could nanostructured drug delivery systems be a novel paradigm for therapy?Enzyme-responsive nanomaterials for controlled drug deliveryChemical basis of interactions between engineered nanoparticles and biological systemsLipid-based surface engineering of PLGA nanoparticles for drug and gene delivery applicationsPolymeric nanoparticles for targeted treatment in oncology: current insightsChemophototherapy: An Emerging Treatment Option for Solid TumorsProtease-Sensitive Nanomaterials for Cancer Therapeutics and Imaging.Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.Topical delivery of anti-TNFα siRNA and capsaicin via novel lipid-polymer hybrid nanoparticles efficiently inhibits skin inflammation in vivo.Modern micro and nanoparticle-based imaging techniquesPoly(ethylene oxide)-block-polyphosphoester-graft-paclitaxel conjugates with acid-labile linkages as a pH-sensitive and functional nanoscopic platform for paclitaxel deliveryEnhancement of biological activities of nanostructured hydrophobic drug species.Spatiotemporal controlled delivery of nanoparticles to injured vasculatureCo-delivery of paclitaxel and tetrandrine via iRGD peptide conjugated lipid-polymer hybrid nanoparticles overcome multidrug resistance in cancer cells.Emerging nanotechnology approaches for HIV/AIDS treatment and prevention.Lipid-polymer nanoparticles encapsulating curcumin for modulating the vascular deposition of breast cancer cells.cRGD-functionalized, DOX-conjugated, and ⁶⁴Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging.Half-antibody functionalized lipid-polymer hybrid nanoparticles for targeted drug delivery to carcinoembryonic antigen presenting pancreatic cancer cells.Nanocarrier for poorly water-soluble anticancer drugs--barriers of translation and solutions.Development of multinuclear polymeric nanoparticles as robust protein nanocarriers.In vitro performance of lipid-PLGA hybrid nanoparticles as an antigen delivery system: lipid composition mattersPreclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile.AS1411 aptamer tagged PLGA-lecithin-PEG nanoparticles for tumor cell targeting and drug delivery.Size matters: gold nanoparticles in targeted cancer drug delivery.Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology.Deep penetration of a PDT drug into tumors by noncovalent drug-gold nanoparticle conjugates.Formulation and optimization of itraconazole polymeric lipid hybrid nanoparticles (Lipomer) using Box Behnken design.Enhanced siRNA delivery into cells by exploiting the synergy between targeting ligands and cell-penetrating peptides.Delivery of nanoparticle: complexed drugs across the vascular endothelial barrier via caveolaeNanoparticle formulations of histone deacetylase inhibitors for effective chemoradiotherapy in solid tumors.Synthesis and characterization of lipid-polymer hybrid nanoparticles with pH-triggered poly(ethylene glycol) shedding.Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.In vivo prevention of arterial restenosis with paclitaxel-encapsulated targeted lipid-polymeric nanoparticlesSite-Specific Drug-Releasing Polypeptide Nanocarriers Based on Dual-pH Response for Enhanced Therapeutic Efficacy against Drug-Resistant Tumors.Clean Photothermal Heating and Controlled Release from Near-Infrared Dye Doped Nanoparticles without Oxygen Photosensitization.Microfluidic based high throughput synthesis of lipid-polymer hybrid nanoparticles with tunable diametersSpatial modulation spectroscopy for imaging and quantitative analysis of single dye-doped organic nanoparticles inside cellsA Near-Infrared Laser-Activated "Nanobomb" for Breaking the Barriers to MicroRNA Delivery.Nanoparticles containing a liver X receptor agonist inhibit inflammation and atherosclerosis
P2860
Q24596232-035BEFCD-970F-4535-AA41-D5BFB722A7D3Q26740363-457E1EC3-F160-4388-9741-883A8FDE35EDQ26992127-39F4FEC2-19B7-4B3E-9F3C-C4F0BD4D1601Q27021154-28F2501E-2576-4034-985A-47087E85F531Q28076544-246BE0EA-5E40-4AB4-B765-8468A5AB620FQ28087243-C7DF8891-BFEF-4BF5-BA84-3053BB92D366Q28468315-BD22EC77-3BA0-42A4-9168-E616B0F48F03Q30355600-05488A94-608C-4A92-9586-80CB7F14197DQ30366990-D7D9748F-6F41-4A04-9283-9C8F7EAC8E21Q30432272-4141E5AF-F77C-4A7A-90DA-46A9F8A88D08Q30459277-2EC522B9-4238-4D36-AA96-5ABD999BD980Q30664584-F9AFBEAD-F59A-4788-8828-5650D42D855AQ33453351-151C2A0F-9543-4377-912B-426BAA64473CQ33529582-545028D0-A20A-4EC7-87DD-DC4930F72757Q33634653-16EF3BAC-76D3-4D8C-910F-5B88C5F4B9C3Q33819656-8378D155-7595-491F-BACD-370A3AE2943CQ33831661-0BEFEEA9-6435-43EB-82AC-B2D2E7BABBF3Q33834952-D5566D03-5649-4DDE-93AF-FD9B810FB56FQ33907575-CAD69566-69EE-4F3D-84DE-7521ADAACF04Q33962553-D9B2468E-F022-45D0-B06B-34882BF4DB56Q34083382-BFC26E65-E868-4406-9C0C-891A30567D51Q34133510-45A55917-C778-40FC-9C03-51A1FC0C6083Q34227677-2CCBFE73-AD4F-40CE-896E-C8E0CC7ED13AQ34276778-943DE1C7-7BA0-41EF-8899-1DBFB708DC73Q34290392-40B64B18-EDAF-411E-9942-89082F0AD444Q34447986-2E5FC4D9-2AF6-4758-B6B0-6C8B73CB2702Q34664629-3A2F1452-BE40-4F1F-AFB3-40CAA14DE911Q35033387-642948F6-374D-4059-9F2B-7A11A9ADABACQ35087556-A7D9F7FF-B00A-4324-98A8-1B83BB6E43B7Q35124272-BFEDDE06-9EFC-4549-B698-35D5CEB1BA17Q35182696-65C7D905-30B6-49F5-ADFA-8862BC92F859Q35193987-033BACE4-EB36-4780-8481-CA49C882BF48Q35201534-D6926FC9-B50E-4200-9493-264E8C88943BQ35585791-08FA6091-2880-409C-919A-1F085391062EQ35633363-C848B140-1E01-4799-945F-4D05531AAE14Q35684637-2A085D14-70E5-43D7-9133-2122A538759CQ35693292-75C30C10-351C-4734-9B33-5B3F3B53C9A3Q35733653-88A5B27A-6948-4DF2-8DA7-5334C19CBBFFQ35841342-60675780-1CAB-410D-BDEC-56628DBF8DBEQ35924658-CBD2ABDA-8612-41AC-A805-DDA54437ABEA
P2860
Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform.
@ast
Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform.
@en
type
label
Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform.
@ast
Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform.
@en
prefLabel
Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform.
@ast
Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform.
@en
P2093
P2860
P50
P921
P356
P1433
P1476
Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform
@en
P2093
Aleksandar F Radovic-Moreno
Frank Alexis
Juliana M Chan
June-Wha Rhee
Liangfang Zhang
Robert Langer
P2860
P304
P356
10.1021/NN800275R
P407
P577
2008-08-01T00:00:00Z